Found: 7
Select item for more details and to access through your institution.
Correction to: Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00891-1
- By:
- Publication type:
- Article
Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.
- Published in:
- Genome Medicine, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13073-021-00891-1
- By:
- Publication type:
- Article
Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival.
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 1, p. 1, doi. 10.1002/pul2.12007
- By:
- Publication type:
- Article
Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension.
- Published in:
- Genome Medicine, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13073-019-0685-z
- By:
- Publication type:
- Article